94 filings
Page 5 of 5
8-K
jc7rz8p3ehxnmsqm5
11 Feb 14
Departure of Directors or Certain Officers
12:00am
8-K
4p2d137qj11hs
7 Feb 14
Submission of Matters to a Vote of Security Holders
12:00am
8-K
iu7p6p49a0r8 iw
4 Feb 14
Departure of Directors or Certain Officers
12:00am
8-K
g772 dzdfz
31 Jan 14
Other Events
12:00am
8-K
re92hw idanuqfm4nw
10 Jan 14
Departure of Directors or Certain Officers
12:00am
8-K
9rnfw26
10 Dec 13
Enanta Pharmaceuticals Announces 96 Percent SVR12 in Treatment Experienced Genotype 1 hepatitis C Patients in SAPPHIRE-II Study
12:00am
8-K
6p2l3q8
26 Nov 13
Departure of Directors or Certain Officers
12:00am
8-K
876wpsm963xorz
25 Nov 13
Results of Operations and Financial Condition
12:00am
8-K
rpaudp
18 Nov 13
Enanta Pharmaceuticals Announces 96 Percent SVR12 in SAPPHIRE-I Study
12:00am
8-K
g95b3a t3qxvi9p
3 Sep 13
Entry into a Material Definitive Agreement
12:00am
8-K
lekgbkudj
21 Aug 13
Departure of Directors or Certain Officers
12:00am
8-K
xj0aj pa5
12 Aug 13
Results of Operations and Financial Condition
12:00am
8-K
hgzis
8 May 13
Results of Operations and Financial Condition
12:00am
8-K
847o4l4ck 7toc6c
28 Mar 13
Amendments to Articles of Incorporation or Bylaws
12:00am